About Kladis Labs
Building the future of sustainable animal nutrition through pioneering strain bioengineering and antimicrobial peptide technology.
Kladis Labs India Pvt. Ltd. is a science-driven biotechnology company specializing in Strain bioengineering and development to produce high-performance feed supplement solutions for Livestock.
Founded in 2022 and headquartered in the global pharmaceutical hub of Hyderabad, we provide high-quality, innovation-driven products that enhance livestock, poultry and aquaculture productivity while supporting sustainable farming practices.
2022
Founded
HQ
Hyderabad, India
High-Quality
Performance Solutions
Antimicrobial resistance (AMR) is one of the most critical challenges in modern animal production. At Kladis Labs, our core scientific focus is the development of next-generation solutions for a post-antibiotic era.
Our focus is on naturally inspired, biologically active molecules that deliver targeted antimicrobial action without contributing to resistance.
Designed to reduce reliance on AGPs while maintaining high performance standards.
Targeted action that supports gut health, immunity and sustainable livestock production.
"AMP-based solutions are designed to bridge the gap between regulatory requirements and farm-level productivity."
At Kladis Labs, Antimicrobial Peptides are not just products—they represent a core technology platform integrated with multi-disciplinary science.
Advanced selection and improvement of microbial hosts for high-efficiency peptide synthesis.
Optimized industrial processes to ensure scalable and consistent bio-active molecule yields.
Innovative delivery systems that preserve potency across diverse species and field conditions.
Explore our range of species-specific solutions for modern animal nutrition.